
Lab management companies, Labguru and Titian Software, have rebranded under a new unified name, Cenevo. This combines their solutions, Mosaic …

Hansa Biopharma has announced three senior leadership appointments to support its global expansion as well as pre-commercial activities in the …

BioDuro and Atombeat have announced a partnership to launch an artificial intelligence (AI)-driven platform designed to accelerate peptide drug discovery …

In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence (NICE) for its dual immunotherapy …

Clinisys has announced the acquisition of Orchard Software from Francisco Partners, strengthening its position in laboratory informatics. The strategic acquisition …

Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in vitro diagnostic regulation-certified blood-based diagnostic …

Sanofi has received approval from the European Commission for the use of Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and …

ViroCell Biologics has announced a new manufacturing collaboration with AvenCell Therapeutics to produce a high-yield retroviral vector supporting the clinical …

Relief Therapeutics has announced that it will combine with NeuroX Group, the successor to digital neurotherapeutics company MindMaze. The transaction …

Based in Brighton, UK, Universal Quantum has joined the Open Quantum Institute (OQI) to explore how quantum computing could revolutionise …

According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions in England have reached their …

Bristol Myers Squibb (BMS) has announced the appointment of Cristian Massacesi as executive vice president, chief medical officer, and head …

Neuraxpharm Group has announced the launch of Neuraxpharm Australia, furthering its global expansion beyond Europe and into key international markets. …

Seaport Therapeutics has dosed its first patient in its phase 2b BUOY-1 study of GlyphAllo (SPT-300), an oral prodrug of …

Cube Biotech has announced a leadership transition as the company continues its trajectory of global growth and innovation in protein …

PureTech Health has announced the departure of chief executive officer (CEO) Bharatt Chowrira, who has stepped down from his role …

OKYO Pharma has announced positive results from its phase 2 trial of urcosimod (formerly OK-101) in neuropathic corneal pain (NCP), …

Yourgene Health, part of the Novacyt group, has announced the launch of LightBench Discover, an integrated benchtop instrument designed to …

UK-based Evestia Clinical will merge with US-based Atlantic Research Group (ARG), forming a leading independent global contract research organisation (CRO) …